Renaissance Technologies
PXMD

Renaissance Technologies’s PaxMedica, Inc. Common Stock PXMD Stock Holding History

Renaissance Technologies’s Portfolio PXMD Stock Details PXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,712
Closed -$28K – 4282
2023
Q3 		$28K Buy
+5,712
New +$55.3K ﹤0.01% 3488

Other funds holding PXMD

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies's PXMD Position: Q4 2023 in Review

Renaissance Technologies sold out of PaxMedica, Inc. Common Stock (PXMD) in Q4 2023, closing a stake of 5,712 shares — an estimated $28K sold.

Renaissance Technologies first reported a position in PXMD in Q3 2023 and held it in 1 quarter. The position peaked at $28K in Q3 2023. 9 funds tracked by Wall St. Rank hold PXMD as of Q4 2023.

  • Renaissance Technologies reported no remaining PaxMedica, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Renaissance Technologies sold 5,712 PaxMedica, Inc. Common Stock shares in Q4 2023, an estimated $28K.
  • Renaissance Technologies first reported a position in PaxMedica, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Renaissance Technologies's PaxMedica, Inc. Common Stock position peaked at $28K in Q3 2023.
  • 9 funds tracked by Wall St. Rank held PaxMedica, Inc. Common Stock as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.